Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: March 31, 2006
Last updated: December 29, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2004
  Estimated Primary Completion Date: No date given